18.09.2022, 1287 Zeichen

Valneva: Valneva, an Austrian/French specialty vaccine company, and IDT Biologika today announced they have agreed to terminate their collaboration following the delivery of inactivated COVID-19 bulk vaccine to Valneva, and considering the current order levels and existing inventories. In light of the reduced European Commission order, Valneva has suspended manufacturing of the vaccine and, as compensation, will pay IDT up to Euro 36.2 mn in cash and the equivalent of Euro 4.5 mn in kind, in the form of specified equipment purchased by Valneva.As per the commercial manufacturing services agreement signed in November 2021, IDT Biologika produced VLA2001 bulk vaccine at its Biosafety Level 3 facilities in Germany, and Valneva bought the batches that were manufactured so far by IDT. 
Valneva: weekly performance: -1.23%

Pierer Mobility: Following the application of the index rules, the composition of the ATX Global Players index will be adjusted. Effective Monday, 19 September 2022, Pierer Mobility will be included and Agrana will be removed from the index. The index rules stipulate that more than 20% of revenues must be generated outside Europe. 
Pierer Mobility: weekly performance: -1.30%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/09/2022)

Christian Drastil: Wiener Börse Plausch

D&D Research Rendezvous #22: Gunter Deuber mit Blick auf den ATX, besonderen Blick auf AT&S, dazu Notenbanken, Standort, KI und Treasury

Bildnachweis

Aktien auf dem Radar:AT&S, Lenzing, Strabag, Austriacard Holdings AG, Semperit, EuroTeleSites AG, Erste Group, FACC, Addiko Bank, voestalpine, Rosgix, Fabasoft, Mayr-Melnhof, Agrana, CPI Europe AG, Telekom Austria, BKS Bank Stamm, Wolford, Amag, Österreichische Post, Symrise, Fresenius Medical Care, Fresenius, Rheinmetall, Deutsche Telekom, Brenntag, SAP, Volkswagen Vz., DAIMLER TRUCK HLD..., Deutsche Post, Siemens Healthineers.

---